TargetMol

UBP551

Product Code:
 
TAR-T8351
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T8351-5mg5mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8351-1mL1 mL * 10 mM (in DMSO)£117.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8351-10mg10mg£131.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8351-25mg25mg£173.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8351-50mg50mg£225.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8351-100mg100mg£301.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8351-200mg200mg£417.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8351-500mg500mg£643.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
UBP551 is a potent and selective NMDA receptors modulator.
CAS:
89-35-0
Formula:
C11H8O4
Molecular Weight:
204.181
Pathway:
Neuroscience
Purity:
0.9877
SMILES:
OC(=O)c1cc2cccc(O)c2cc1O
Target:
NMDAR

References

Costa B M , Irvine M W , Fang G , et al. A Novel Family of Negative and Positive Allosteric Modulators of NMDA Receptors[J]. Journal of Pharmacology & Experimental Therapeutics, 2010, 335(3):614-621. Monaghan DT, Irvine MW, Costa BM,et al. Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.[J]. neurochemistry international, 2012, 61(4):581-592.